by: manilatimes
by: Zawya
by: Indiatimes
Scientists discover hidden 'ice quakes' deep inside Greenland's ice streams for the first time
by: Zawya
by: MSN
Jeff Bezos' rocket company is slashing 10% of its workforce a month after debut orbital launch
by: MSN
Modi-Trump talks: AI, hi-tech, semiconductors in focus as India, US pledge to boost tech ties
by: MSN
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
The funds will be used for general corporate purposes, with a focus on reducing operating expenses and exploring strategic alternatives for MAT2203, the Company's Phase 3-ready antifungal drug candidate for the treatment of invasive fungal infections, as well as other strategic alternatives for the Company.

Read the Full manilatimes Article at:
https://www.manilatimes.net/2025/02/14/tmt-newswire/globenewswire/matinas-biopharma-announces-agreement-for-the-acquisition-of-preferred-stock-and-appointment-of-dr-robin-l-smith-to-the-board-of-directors/2055773
on: Mon, Feb 10th 2025
by: MSN
Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say
on: Mon, Jan 13th 2025
by: MSN
UK must do more to lead innovation in bio-tech sector, Lords committee says
on: Fri, Jan 10th 2025
by: FierceBiotech
Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund
on: Wed, Dec 11th 2024
by: MSN
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript